| 发明名称 |
Treatment of mood disorders by administration of SMR1 |
| 摘要 |
This invention relates to the use of an agent that modulates the interaction between a SMR1 peptide and a metal-lopeptidase for the preparation of a medicament for preventing or treating a Central Nervous System disorder giving rise to a mental disorder. |
| 申请公布号 |
US7423020(B2) |
申请公布日期 |
2008.09.09 |
| 申请号 |
US20030451073 |
申请日期 |
2003.12.30 |
| 申请人 |
INSTITUT PASTEUR;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) |
发明人 |
ROUGEOT CATHERINE;ROUGEON FRANCOIS |
| 分类号 |
A61K38/00;G01N33/50;A01N37/18;A61K38/05;A61K38/12;A61K38/22;A61K45/00;A61P1/12;A61P9/10;A61P9/12;A61P13/02;A61P25/00;A61P25/04;A61P25/14;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P27/00;A61P29/00;A61P31/04;A61P31/12;A61P35/00;A61P43/00;C07K14/575;C12Q1/02;C12Q1/37;G01N33/15;G01N33/566 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
